E-ISSN 2149-388X | ISSN 2149-0430
 

Letter to the Editor 


Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?

Oluwanisola Akanji Onigbinde.

Abstract
Since late December 2019 to date, the world has continued in the fight against the recent most dreaded coronavirus, severe acute respiratory syndrome 2 (SARS-CoV-2) that is ravaging the world. With the daily geometric increased in infected cases and death toll globally, it was predicted that Africa will suffer the most from the havoc of the coronavirus disease 2019 (COVID-19) pandemic. This prediction could be traced to the dilapidated health care delivery systems, overcrowding, and the high rate of corruption in the continent. However, the claws of this virus seem to have spared the shores of Africa as the death toll in this continent is too low if compared with developed countries with state-of-the-earth facilities. This has led to Africans claim of immunity or resistance to SARS-CoV-2 and that the virus is a 'White man's virus'. Are Africans truly immune to SARS-CoV-2? Should this self-acclaimed immunity or resistance be explored or ignored? Hence this study.

Key words: SARS-CoV-2, Africa, immunity, resistance, COVID-19


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Oluwanisola Akanji Onigbinde
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Oluwanisola Akanji Onigbinde. Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?. Ulutas Med J. 2021; 7(2): 141-144. doi:10.5455/umj.20210219111336


Web Style

Oluwanisola Akanji Onigbinde. Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?. http://www.ulutasmedicaljournal.com/?mno=57378 [Access: June 25, 2021]. doi:10.5455/umj.20210219111336


AMA (American Medical Association) Style

Oluwanisola Akanji Onigbinde. Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?. Ulutas Med J. 2021; 7(2): 141-144. doi:10.5455/umj.20210219111336



Vancouver/ICMJE Style

Oluwanisola Akanji Onigbinde. Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?. Ulutas Med J. (2021), [cited June 25, 2021]; 7(2): 141-144. doi:10.5455/umj.20210219111336



Harvard Style

Oluwanisola Akanji Onigbinde (2021) Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?. Ulutas Med J, 7 (2), 141-144. doi:10.5455/umj.20210219111336



Turabian Style

Oluwanisola Akanji Onigbinde. 2021. Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?. THE ULUTAS MEDICAL JOURNAL, 7 (2), 141-144. doi:10.5455/umj.20210219111336



Chicago Style

Oluwanisola Akanji Onigbinde. "Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?." THE ULUTAS MEDICAL JOURNAL 7 (2021), 141-144. doi:10.5455/umj.20210219111336



MLA (The Modern Language Association) Style

Oluwanisola Akanji Onigbinde. "Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?." THE ULUTAS MEDICAL JOURNAL 7.2 (2021), 141-144. Print. doi:10.5455/umj.20210219111336



APA (American Psychological Association) Style

Oluwanisola Akanji Onigbinde (2021) Acclaimed African Immunity or Resistance to Sars-Cov-2: Explore or Ignore?. THE ULUTAS MEDICAL JOURNAL, 7 (2), 141-144. doi:10.5455/umj.20210219111336